Meditope Biosciences Garners $3,600,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=99baaf26-9ff7-4fe1-bea8-1dda3bfe944c
Date
7/27/2013
Company Name
Meditope Biosciences
Mailing Address
301 North Lake Avenue Pasadena, CA 91101
Company Description
Discovered at City of Hope, Meditope’s technology is capable of turning any monoclonal antibody (mAb) into a proprietary, site-specific “Lego-like” system that is able to attach and detach drugs to antibodies without the need for chemical conjugation.
Website
http://www.meditope.com
Transaction Type
Venture Equity
Transaction Amount
$3,600,000
Transaction Round
Series A
Proceeds Purposes
The company will use the proceeds to accelerate development of its antibody-based cancer products.
M&A Terms
Venture Investor
Undisclosed